NCT01500577View on ClinicalTrials.gov

A Prevention Trial in Subjects at High Risk for Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2012

Study Completion Date

July 31, 2013

Conditions
Breast Cancer
Interventions
DRUG

nimesulide

Nimesulide 100 mg (capsules). 100mg/die every day for 1 year. Oral administration

DRUG

Simvastatin

Simvastatin 20 mg (capsules). 20mg/die every day for 1 year. Oral administration

OTHER

Placebo

Placebo (capsules). 1 cps/die every day for 1 year. Oral administration

Trial Locations (1)

Unknown

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER

NCT01500577 - A Prevention Trial in Subjects at High Risk for Breast Cancer | Biotech Hunter | Biotech Hunter